Purpose Stunning of thyroid remnants after diagnostic scanning (Dx-WBS) using radioactive
iodine-131 (131 I) may limit the efficacy of 131 I therapy. We aimed to evaluate this …

Thyroid stunning is usually defined as decreased uptake or trapping of radioiodine 131I by
normal thyroid tissue or differentiated thyroid cancer after diagnostic administration of 131I …

Aim The aim of this paper was to explore by a quantitative method whether a 74 MBq 131I
scanning activity produces a stunning effect in patients with differentiated thyroid carcinoma …

The use of 131I in doses of several mCi for scans can stun the thyrocytes and thyroid cancer
cells, whereas the usual dose (300 μCi) of 123I does not. We compared the diagnostic …

Background In the management of patients with differentiated thyroid carcinoma, direct
comparison of the presence of scintigraphic stunning after a diagnostic dose of 131 I with …

Debates regarding thyroid stunning—a phenomenon whereby a diagnostic dose of
radioiodine decreases uptake of a subsequent therapeutic dose by remnant thyroid tissue or …

Recent publications described many discrepant findings about thyroid “stunning” after the
administration of 131I diagnostic activities to patients with differentiated thyroid carcinoma …

PURPOSE: To determine if stunning can be seen with a 185-MBq (5-mCi) dose of iodine
131 (131I) at diagnostic whole-body scanning and, if stunning is seen, determine if there is …

" Thyroid stunning" from diagnostic iodine-131 imaging prior to ablative therapy with 131 I for
well-differentiated thyroid carcinoma has been well reported, but documentation of the effect …

Stunning of thyroid remnants after diagnostic scanning with 131I may limit 131I therapy. The
follow-up scans and serum thyroglobulin levels of such patients have been studied …